通过瘤衍生的外体EPHA2通过LDHA介导的M2型巨细胞两极化促进细胞癌的进展
Xinxin Gan1,2, Jiatao Hu1, Qingyang Pang1
1Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
Molecular carcinogenesis
|May 23, 2024
概括
在清细胞细胞癌 (ccRCC) 中,高乳酸脱酶A (LDHA) 表达促进瘤进展,通过通过外体EPHA2增强M2巨细胞极化,建议EPHA2作为治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 乳酸脱酶A (LDHA) 与瘤生长,入侵和免疫逃生有关.
- LDHA在重塑瘤微环境和促进细胞癌 (RCC) 进展中的作用尚未完全理解.
研究的目的:
- 研究LDHA在清细胞RCC (ccRCC) 进展中的作用.
- 阐明LDHA影响瘤微环境的机制,特别是巨细胞两极分化.
- 确定高级RCC的潜在治疗点.
主要方法:
- 在ccRCC组织中分析LDHA表达.
- 在体内和体外实验中使用ccRCC细胞系和巨细胞进行实验.
- 研究ccRCC细胞和巨细胞之间的外体介导通信.
- 对PI3K/AKT/mTOR通路激活的评估.
主要成果:
- 在ccRCC中LDHA的表达很高,并且与巨细胞透率的增加相关.
- 高LDHA表达和M2型巨细胞增强了ccRCC细胞的增殖,入侵和迁移.
- 在ccRCC细胞中,LDHA调高了外体EPHA2的调节.
- 外体EPHA2通过PI3K/AKT/mTOR通路促进了M2巨细胞的两极分化,推动了ccRCC的进展.
结论:
- 通过外体EPHA2调节巨细胞透和M2极化,LDHA促进ccRCC的进展.
- LDHA-外体EPHA2-M2巨轴代表了ccRCC病变发生的一个新机制.
- EPHA2成为高级RCC的有前途的治疗点.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


